Axel Schulz | White & Case LLP International Law Firm, Global Law Practice
Axel Schulz
Axel Schulz

Axel Schulz

Partner, Brussels

T +32 2 239 25 87

T +32 2 239 26 20


in LinkedIn profile

A partner in the Firm’s Brussels office, Axel Schulz’s advisory practice focuses on merger control, cartel defence and competition law disputes before the European courts.


Axel supports clients with a broad range of German and European Commission competition law matters.

He offers clients the benefit of his significant experience in this field, having handled merger control cases involving collective dominance and countervailing buyer power, as well as structural links issues in industries including aluminum, paper, energy, automotive, pharmaceuticals and medical devices.

Axel's varied sector knowledge is matched by his deep understanding of the cross-border intricacies of competition and antitrust law. The international dimension to his practice enables him to guide both domestic and multinational companies through whatever competitive issues they are faced with, regardless of their scale or multijurisdictional complexity.

Axel's significant track record in this area includes a number of high profile cases, such as 'Toshiba v. Commission' – in which the General Court of the European Union annulled in full the €90.9 million fine imposed on Toshiba by the European Commission, for its alleged participation in the Gas Insulated Switchgear cartel. He also worked on Toshiba's Cathode Ray Tube appeal, as well as the oral hearings in T-113/07 before the European Court of Justice, and the Transformers (Case COMP/39.129) hearing before the General Court.

Regularly called upon to head up teams of the Firm's lawyers, Axel is also noted for his skill in coordinating advice across multiple offices and territories, to provide his clients with clear and creative solutions to their problems.

Axel is a particularly valued resource for clients in the pharmaceutical industry. Recognized as a leading life sciences lawyer by Who's Who Legal 2012, he has developed a strong track record of helping clients with competition law issues in the fields of distribution, co-marketing, licensing and other kinds of vertical and horizontal cooperation agreements.

A respected authority on the latest competition and antitrust issues, Axel writes regularly for leading legal publications and was honored with the Institute of Competition Law's 2012 Antitrust Writing Award.

Bars and Courts

  • Munich Bar
  • Brussels Bar (E list)


  • LLM, European Law, College of Europe, Bruges
  • Law Degree, University of Konstanz
  • Diploma, University of Lyon


  • English
  • French
  • German
  • Italian


Speaking Engagements

"Round table on Cartels – Dawn raids", 11 September 2014: QED – EU Competition Law Summit, Brussels

"Online sales", 25 June 2014: IBC Legal Conferences – Vertical Agreements: Practical Experience with Reg. 330/2010, Brussels, Presentation

"Pharma Sector Competition Law Developments", 7 September 2011: IBC Pharmaceutical Law Academy, London, Presentation

"The Latest Regulatory Developments and Proven Successful Strategies for Patent Lifecycle Extensions in Light of Recent European and US Case Law", 21–22 June 2011: C5 – 10th Annual Forum on Pharma Patent Lifecycles, London, Presentation

"Parallel- und Re-Import von Arzneimitteln", 21 September 2010: Colloquium Pharmaceuticum, Frankfurt, Germany, Presentation

IBC Biotech & Pharmaceutical Patenting 2010, 17 February 2010: Munich, Germany


  • The rules on information exchanges under European competition law, 41 Kokusai Shôji Hômu 665, 2013, (published in Japanese) (co-author, with P. Berghe and T. Onoki)
  • Recent developments in relation to parallel trade in the European pharmaceuticals sector, ", Biotechnology and Life Sciences Sector – Strategies for Growth, Survival and Patent Protection,, Financier Worldwide, January 2010 (co-author)
  • Who is the Predator (2)? The French Competition Council's GSK Predation Decision is Overruled, Competition Law Insight, July 1, 2008, (co-author)
  • French Competition Council vs. GSK France: who is the predator?, Competition Law Insight, June 2007, (co-author)
  • Vertical Mergers" in "EC Competition Law – A Critical Assessment, ed. Prof. Amato and Prof. Ehlermann, Hart Publishing, May 2007, Chapter
  • Lloyd's Law Report, Pharma, from January to December 2007, European Editor
  • Special status of IP in the pharmaceutical industry, BNA International, May 2006
  • Competition law in the food industry, (part of a ten-module training course "Food Law and Regulation"), Informa, June 2006, Module
  • Marketing & Distribution in the Pharmaceutical Industry, Informa, December 2005., part of a ten-module training course "Pharmaceutical Law and Practice"
  • Parallel trade in Europe – the tide is turning, Pharmaceutical Law, Insight, December 2005, (co-author)

Awards & Recognition

Recommended for Antitrust law, JUVE, 2016

Mention: Competition: EU and global, Legal 500, EMEA 2016

Leading Lawyer: Life Sciences, Who's Who Legal 2012

Best Business Anticompetitive Practices Article, Antitrust Writing Awards 2012

Institute of Competition Law